🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Herbert I. Hurwitz

Duke University

ORCID: 0000-0003-3242-9197

Also affiliated with Duke Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.694Author DataRank

Indexed papers

5in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2386
Top 29%
0.694DataRank
Top 29%11 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Papers

Driven by 11 papers — median percentile 0. Top paper: “Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer”.

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.49040
N/A
3.5DataRank · unranked
127 citations

Fang‐Shu Ou, Tyler Zemla, Þorvarður R. Hálfdánarson, Heinz‐Josef Lenz, Rimini Breakstone +11 more

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

New England Journal of Medicine(2004)10.1056/nejmoa032691
N/A
1.4DataRank · unranked
10954 citations

Louis Fehrenbacher, William Novotny, Thomas Cartwright, John Hainsworth, William Heim +18 more

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2386
Top 29%
0.694DataRank
Top 29%11 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303

UNC Libraries(2020)10.17615/m9r7-sb16
Top 100%
0DataRank
Top 100%0 citations

Kathleen M. Giacomini, Richard L. Schilsky, Paula N. Friedman, Taisei Mushiroda, Herbert I. Hurwitz +16 more

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2389
N/A
0DataRank · unranked
20 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)

UNC Libraries(2020)10.17615/j1vn-2e47
N/A
0DataRank · unranked
7 citations

Ace J. Hatch, Alexander B. Sibley, Andrew B. Nixon, J. Chris Brady, Jingquan Jia +9 more

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-0226
N/A
0DataRank · unranked
57 citations

Kirsten B. Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu +16 more

Data from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

(2023)10.1158/1078-0432.c.6531153
Top 100%
0DataRank
Top 100%0 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

(2023)10.1158/1078-0432.c.6531354
Top 100%
0DataRank
Top 100%0 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

(2023)10.1158/1078-0432.c.6531354.v1
Top 100%
0DataRank
Top 100%0 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

A causal inference framework for leveraging external controls in hybrid trials

Biometrics(2024)10.1093/biomtc/ujae095
N/A
0DataRank · unranked
4 citations

Herbert I. Hurwitz, Jiawen Zhu, Stephen R. Cole, Michele Jönsson Funk, Michael R. Kosorok +1 more